Showing results (261-270 of 592) with videos related to
Sort By:
Pageof 60
Oncotarget|November 7, 2015
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical dataGiulia Pasello, Loredana Urso, Manlio Mencoboni, et al.Current Drug Targets|March 31, 2012
Molecular and genetic bases of pancreatic cancerVanja Vaccaro, Alain Gelibter, Emilio Bria, et al.Critical Reviews in Oncology/Hematology|June 23, 2019
Muscle derangement and alteration of the nutritional machinery in NSCLCIlaria Trestini, Anastasios Gkountakos, Luisa Carbognin, et al.Cancers|August 14, 2019
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundAnastasios Gkountakos, Giulia Sartori, Italia Falcone, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2010
Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapyMark G Kris, Maurizio Tonato, Emilio Bria, et al.Journal of Experimental & Clinical Cancer Research : CR|May 28, 2010
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trialsFotios Loupakis, Emilio Bria, Vanja Vaccaro, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 12, 2016
International Experts Panel Meeting of the Italian Association of Thoracic Oncology on Antiangiogenetic Drugs for Non-Small Cell Lung Cancer: Realities and HopesFilippo de Marinis, Emilio Bria, Fortunato Ciardiello, et al.Peerj|August 9, 2019
Neutrophil-lymphocyte ratio is prognostic in early stage resected small-cell lung cancerZoltan Lohinai, Laura Bonanno, Aleksei Aksarin, et al.Critical Reviews in Oncology/Hematology|December 8, 2015
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trialsFrancesco Massari, Alessandra Modena, Chiara Ciccarese, et al.Cancer|October 20, 2011
Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer: meta-analytical estimation and implications for therapeutic strategiesFotios Loupakis, Chiara Cremolini, Lisa Salvatore, et al.Pageof 60